Motley Fool  Nov 7  Comment 
The drug-delivery specialist experienced revenue growth in all business lines and upped its full-year 2015 guidance.
Motley Fool  Nov 6  Comment 
Strong growth on the top line combined with an upbeat forecast sends shares higher.
Motley Fool  Aug 13  Comment 
Insulet Corporation's stock slumped in early morning trading today. Here's why.
Motley Fool  Jul 30  Comment 
Insulet Corporation pre-announced second-quarter results that are better than previously forecast.
Forbes  Jun 2  Comment 
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they...
TheStreet.com  May 1  Comment 
NEW YORK (TheStreet) -- Insulet shares fell sharply in intraday trading, down 9.65% to $26.97, on Friday after the insulin infusion company reported its first quarter earnings results after the closing bell yesterday.The company reported a...

You may also be interested in articles related to Insulet (PODD):

Insulet (PODD) is competing against Mini Med, a division of Medtronic, for the insulin delivery system segment. The product has a needle which is inserted until an audible sound is heard, then the needle withdraws leaving behind a tethlon tube. Insuline is dripped from the pod into the body via the tube. When the pod is low on the solution, more is added. This avoids the nasty needle sticks many diabetics loath. The pod can be worn many places on the body and has no major tubes of complicated computer readouts, vs. the typical insulin pump. Often a physician asks the patient to try wearing the pod while it drips saline. Uptake is high afterwards as the pod is so comfortable.

Per the CEO, Duane Desisto, they may have a pump company burried in a pod company. Meaning that other drugs may be delivered via the pod.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki